1612 — Vincent Medical Holdings Income Statement
0.000.00%
Last trade - 00:00
- HK$307.07m
- HK$169.92m
- HK$717.97m
- 96
- 98
- 80
- 100
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 502 | 1,155 | 778 | 629 | 718 |
Cost of Revenue | |||||
Gross Profit | 162 | 494 | 259 | 165 | 240 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 479 | 863 | 703 | 640 | 652 |
Operating Profit | 23.6 | 292 | 74.5 | -11 | 65.8 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 18.3 | 284 | 66.2 | -15.5 | 66.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | 12.9 | 247 | 60.1 | -18.4 | 58.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 11.5 | 217 | 60.7 | -17.4 | 57.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 11.5 | 217 | 60.7 | -17.4 | 57.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.029 | 0.348 | 0.111 | -0.022 | 0.09 |
Dividends per Share | |||||
Special Dividends per Share |